from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2952/-

LFCtreatmentdescriptionclass of inhibitor

0.256

Amikacinug/mL Amikacintranslation

1.102

Cap5-10ug/mL Capreomycintranslation

1.617

Rox10-50 ug/mL Roxithromycintranslation

0.640

SM2-5 ug/mL Streptomycintranslation

0.802

Tet5-10 ug/mL Tetracyclinetranslation

0.188

Rif0.2-5ug/mL Rifampicintranscription

-0.474

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.311

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.475

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.901

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.912

Clofazimine10-13 ug/mL Clofaziminerespiration

0.044

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.796

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.383

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.424

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.215

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.891

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.551

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.872

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.114

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.572

KCN5-20 ug/mL Potassium cyaniderespiration

-0.714

NaN30.2-2 mM Sodium aziderespiration

1.430

Nigericin50 uM Nigericinrespiration

-0.858

TRC10-150 ug/mL Triclosanrespiration

-1.837

TRZ10-25 ug/mL Thioridazinerespiration

-1.080

Valinomycin0.5-10 uM Valinomycinrespiration

1.090

ZnSO42 mM ZnSO4respiration

-0.242

menadione6-10 ug/mL Menadionerespiration

-0.298

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.811

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.238

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.241

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.452

NRP_1Non-replicating persistence stage 1dosRassociated

0.843

Amp0.2mg/mL AmpicillincellWall

0.750

Cephalexin20-100 ug/mL CephalexincellWall

1.232

Cerulenin0.32-5 ug/mL CerulenincellWall

0.842

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.000

EMB10-20 ug/mL EthambutolcellWall

0.989

Eta12-40 ug/mL EthionamidecellWall

1.045

INH0.2-0.4 ug/mL IsoniazidcellWall

0.519

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.329

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.730

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.519

BZA0.12 mg/mL BenzamidearomaticAmides

-0.107

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.055

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.066

H2O24 mM hydrogen peroxideDNAdamaging

0.294

Levo10 ug/mL LevofloxacinDNAdamaging

0.856

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.213

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.666

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.603

UVUV-irradiationDNAdamaging

-0.998

ARP41-4 ug/mL Antitubercular compound ARP4?

0.656

Antimycin12.5-50 ug/mL Antimycin A?

0.753

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.188

PA_110-50 ug/mL Antitubercular compound PA-1?

0.235

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.876

PA8240.2-2 ug/mL PA-824?

-0.902

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.379

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.529

Verapamil50 uM Verapamil?

0.931

mercaptoethanol2 mM 2-Mercaptoethanol?

0.659

methoxatin10-20 ug/mL Methoxatin?